SAB Biotherapeutics Announces Clinical Partnership with

SIOUX FALLS, S.D., March 25, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), (“SAB” or the “Company”), a clinical-stage...

Related Keywords

United States ,Maryland ,Nehkonti Adams ,Samuelj Reich ,Development Agreement ,Exchange Commission ,Nasdaq ,Navy Medical Research Command ,Navy Medical Research ,Henry Jackson Foundation ,Twitter ,Drug Administration ,Clinical Trials Center ,Biotherapeutics Inc ,Linkedin ,Cooperative Research ,Trials Center ,Breakthrough Therapy ,Fast Track Designations ,Private Securities Litigation Reform Act ,Nasdaq Sabs ,Sab Biotherapeutics ,Nc ,